Oncternal Therapeutics In... (ONCT)
undefined
undefined%
At close: undefined

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY00 FY99
Net Income -39.48M -44.17M -31.33M -17.23M -34.19M -38.42M -30.44M -17.72M -18.70M -39.41M -42.11M -45.91M -33.29M 15.29M -46.26M -51.78M -40.36M -35.51M -36.84M -22.35M -14.19M -11.87M -3.81M -750.00K
Depreciation & Amortization - -75.00K 169.00K 150.00K - 46.00K 47.00K 28.00K 43.00K 102.00K 384.00K 750.00K 1.04M 1.57M 1.78M 1.56M -4.90M -5.01M -299.00K -580.00K 357.00K 332.00K 80.00K 45.00K
Stock-Based Compensation 7.50M 7.43M 5.88M 1.56M 507.00K 2.20M 3.15M 2.96M 2.62M 4.43M 3.73M 2.65M 4.23M 4.89M 5.17M 3.71M 2.04M 1.26M 639.00K 804.00K 550.00K - - -
Other Working Capital 3.04M -1.03M -2.12M -1.95M 2.25M -4.01M 2.23M 1.15M -897.00K -2.81M -3.85M 3.64M 1.18M -1.43M 5.95M 53.68M 5.18M 27.47M 800.00K 61.30M 12.78M 827.00K - -
Other Non-Cash Items -1.46M 179.00K 169.00K -151.00K 19.45M 166.00K 166.00K 132.00K 113.00K 422.00K 135.00K 169.00K -8.07M -51.79M -11.15M -10.96M 2.22M 1.40M 852.00K 804.00K 550.00K - 3.73M 705.00K
Deferred Income Tax - - -169.00K -150.00K - - - -8.16M -3.08M 8.80M -1.37M - 1.78M 1.69M - 34.00K -2.17M -1.02M -639.00K -804.00K -550.00K - - -
Change in Working Capital 1.27M -69.00K -1.30M -1.68M -2.51M -3.34M 3.62M 1.99M -1.03M -3.10M -4.75M 5.23M 1.23M -2.18M 4.45M 54.50M 5.53M 27.42M 1.47M 6.45M 290.00K 981.00K - -
Operating Cash Flow -32.16M -36.70M -26.59M -17.50M -16.75M -39.35M -23.46M -20.78M -20.04M -28.76M -43.97M -37.11M -33.09M -30.53M -46.00M -2.92M -37.63M -11.46M -34.82M -15.67M -13.00M -10.55M - -
Capital Expenditures - - - - - - -2.00K -90.00K -4.00K -5.00K -32.00K -142.00K -54.00K -95.00K -600.00K -2.90M -1.74M -578.00K -935.00K -1.17M -108.00K -313.00K - -
Acquisitions - - - - 16.14M - -24.16M -37.65M -71.43M -10.69M - 18.90M -2.45M -16.94M -2.45M - - - - - - - - -
Purchase of Investments -64.35M -26.50M - - - -44.16M -39.28M -35.40M -55.22M -41.91M -1.43M -11.98M -15.14M -8.57M -11.28M - - - - - - - - -
Sales Maturities Of Investments 65.00M - - - - 72.04M 24.16M 37.65M 71.43M 10.69M 9.27M 14.63M 4.90M 16.94M 2.45M - - - - - - - - -
Other Investing Acitivies - -26.50M - - -2.15M 72.04M 24.16M 37.65M 71.43M 10.69M 1.42M 14.63M 2.45M 16.94M 2.45M - -513.00K -240.00K -446.00K -4.83M - - - -
Investing Cash Flow 651.00K -26.50M - - 16.14M 27.88M -15.13M 2.15M 16.21M -31.22M 9.24M 21.41M -10.30M 8.28M -9.43M -2.90M -1.74M -578.00K -1.38M -6.00M -108.00K -313.00K - -
Debt Repayment - - - 301.00K - - - - - -2.00K -7.00K -82.00K -85.00K -88.00K -5.00K -5.00K -5.00K -5.00K -4.00K - - - - -
Common Stock Repurchased -156.00K -3.00K - - - - - - - - - - - - - - - - - - - - - -
Dividend Paid - - - - - - - - - - - - - - - - - - - -455.00K -3.44M - - -
Other Financial Acitivies - - 617.00K 4.00K 15.00K -569.00K -156.00K -211.00K - -617.00K 1.23M 85.00K 55.00K 9.00K 136.00K 1.17M 826.00K - - -433.00K -1.04M 10.96M - -
Financial Cash Flow 1.07M 9.58M 617.00K 114.18M 15.00K 23.91M 45.49M 13.48M - 63.33M 1.22M 3.00K 48.95M 40.21M 131.00K 1.16M 20.00M 57.57M 45.69M 71.43M 18.95M 10.96M - -
Net Cash Flow -30.45M -53.62M -25.97M 96.69M -594.00K 12.44M 6.91M -5.15M -3.82M 3.35M -33.52M -15.70M 5.56M 17.96M -55.29M -4.67M -19.37M 45.54M 9.49M 49.76M 5.84M 91.00K - -
Free Cash Flow -32.16M -36.70M -26.59M -17.50M -16.75M -39.35M -23.46M -20.87M -20.04M -28.76M -44.00M -37.25M -33.14M -30.62M -46.60M -5.83M -39.37M -12.04M -35.75M -16.84M -13.11M -10.87M - -